Institutional investors purchased a net $7.6 million shares of ATRS during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 36.94% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 5.7 Million shares of Antares Pharma Inc
SSGA FUNDS MANAGEMENT, INC. Bought 2.0 Million shares of Antares Pharma Inc
NORTHERN TRUST INVESTMENTS, INC. Bought 1.4 Million shares of Antares Pharma Inc